You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cardioselective beta-blockers, particularly atenolol, showed minimal impact on lung function (FEV1) in asthmatic patients. Non-cardioselective beta-blockers significantly reduced FEV1 and blocked bronchodilator responses.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: